91社区

At this early stage, the potential for harm is real while the benefits are only surrogate measures, said Kimmelman, an associate professor of biomedical ethics at 91社区. One such measure at Phase 1 might be tumor shrinkage, which does not necessarily translate into what people really care about: survival.